IBM Stock Surges As Quantum Foundry And $10B Plan Ignite Rally

International Business Machines Corporation stocks have been trading up by 12.81 percent on strong AI-driven enterprise demand and partnerships.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading IBM

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

What Traders Need To Know

U.S. backing and IBM capital are funding Anderon, a 300mm quantum wafer foundry in Albany, the first U.S. pure‑play quantum chip plant focused on superconducting qubits.
Management plans to deploy over $10B into quantum computing by 2029, targeting a large-scale fault‑tolerant system and expanding an already sizable partner ecosystem.
The stock has already jumped between roughly 7% and 12% on heavy volume as traders price in billions in proposed U.S. quantum support and the new American quantum chip foundry.
Wedbush keeps an Outperform view on IBM, pointing to underappreciated AI and quantum leadership and noting price targets ranging from $225 to $320.
Project Lightwell, a $5B AI‑driven security push with Red Hat, adds a nearer‑term software and cybersecurity revenue angle to the longer‑dated quantum roadmap.

Weekly Update May 25 – May 29, 2026: On Friday, May 29, 2026 International Business Machines Corporation stock [NYSE: IBM] is trending up by 12.81%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Technology industry expert:

Analyst sentiment – positive

IBM now sits in the upper tier of large-cap enterprise tech with a defensible hybrid cloud, AI, and mainframe franchise, delivering solid but not hyper-growth fundamentals. Revenue growth in the mid‑single digits (3–6% range) and gross margin of 58% underpin attractive EBIT margin of 18% and ROE above 30%, albeit boosted by leverage (D/E 2.1x, current ratio 0.8). Free cash flow is strong (c. $4.9B in the latest quarter vs. $6.8B in net income annualized), supporting a 2.6% dividend yield at roughly 11x FCF. Balance sheet risk is manageable but not trivial given $60B+ long-term debt and significant goodwill/intangibles.

Technically, IBM is in a powerful weekly uptrend: successive closes from $249.8 to $297.5 over four weeks, with each week making higher highs and higher lows, signaling strong institutional accumulation on elevated volume after quantum-related headlines. Short-term 5‑minute candles show healthy intraday pullbacks being bought, with no sign of exhaustion selling yet. The key actionable level is $280: this was a recent breakout zone and should now act as first major support and tactical add-on level on any pullback.

More Breaking News

IBM’s quantum and AI announcements, backed by ~$1B in U.S. grants and $10B+ of planned quantum investment, position it as a core beneficiary of government-backed strategic compute and security spending, ahead of most Software & IT Services peers on quantum exposure but lagging in pure-play AI growth versus hyperscalers. Project Lightwell and security initiatives enhance high-margin software and consulting mix. I see IBM outperforming tech benchmarks over 12–24 months, with near-term support at $280, stronger support at $250, resistance around $320, and a 12‑month upside target of $325.

Quick Financial Overview

International Business Machines Corporation (IBM) is trading in a sharp uptrend on the weekly chart. In recent weeks, price has pushed from the mid‑$240s to just under $300, with the most recent weekly close near $297.54. That move mirrors the strong news flow: U.S. grants and equity backing for quantum, the Anderon foundry plan, and a stated $10B quantum spend over five years. For short‑term traders, this is classic news‑driven momentum layered on top of a multi‑week breakout.

On the intraday tape, the latest session shows a wide range between the low $270s in premarket and prints above $300 into the afternoon, before a slight fade to the high $290s by the close. Volume is not provided, but price swings of more than $25 in a day tell you volatility has expanded. The 5‑minute candles show repeated dips being bought around the mid‑$280s to low‑$290s, while sellers appear near $300–$301, giving traders very clear intraday levels to frame risk.

Under the hood, IBM’s fundamentals support this re‑rating narrative. Revenue stands near $67.5B with revenue growth in the mid‑single digits over three and five years, while profit margins remain solid with EBIT margin above 18% and gross margin near 58%. Cash generation is strong: quarterly operating cash flow is about $5.17B and free cash flow sits around $4.94B, even after heavy investing activity, which helps fund quantum and AI projects. Leverage is high with total debt to equity above 2 and a current ratio below 1, so traders should respect the balance‑sheet risk, but returns on equity are robust above 20%, signaling efficient use of that leverage.

Conclusion

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!